Efficacy of cetuximab plus PD-1 inhibitor differs by HPV status in head and neck squamous cell carcinoma: a systematic review and meta-analysis

BACKGROUND: The addition of cetuximab significantly increased the antitumor effect of programmed cell death protein 1 (PD-1) inhibitors in recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). However, preliminary analyses suggested that human papillomavirus (HPV)-positive disease b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Siqi, Zheng, Mengge, Nie, Deheng, Xu, Lili, Tian, Huimin, Wang, Mengmeng, Liu, Wenjia, Feng, Zhenbang, Han, Fujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577924/
https://www.ncbi.nlm.nih.gov/pubmed/36253001
http://dx.doi.org/10.1136/jitc-2022-005158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577924/
https://www.ncbi.nlm.nih.gov/pubmed/36253001
http://dx.doi.org/10.1136/jitc-2022-005158

Ejemplares similares